← Human Trials & Peer-Reviewed Studies
Socioeconomic Disparities in Childhood Obesity Risk: Association With an Oxytocin Receptor Polymorphism
Plain-language guide to PMID 27842184 (2017): observational study of Oxytocin.
Key Facts
- PMID
- 27842184
- Journal
- JAMA pediatrics
- Year
- 2017
- Study type
- Observational Study
- Authors
- Bush NR et al. (6 authors)
- DOI
- 10.1001/jamapediatrics.2016.2332
What This Study Did, in Plain Language
What Was Tested
Researchers studied Oxytocin in this observational study publication.
To examine whether an OT receptor polymorphism (rs53576) interacts with SES, potentially exacerbating and buffering the effects of stress, to predict anthropometry during childhood, and based on differential neurobiological susceptibility theory, to test whether carriers of the A allele of the OXTR gene, compared with GG genotyped individuals, would be most sensitive to the effects of SES on anthropometry for better or for worse.
Why It Was Studied
Low SES is a robust predictor of obesity across the life course and may interact with genes affecting metabolism to influence obesity risk.
To date, this association has not been examined in children.
Who Took Part
The age groups tagged for this paper are children, both men and women.
In this observational study, families were recruited from public school classrooms and enrolled in the Peers and Wellness Study (PAWS), which examined the effects of social status on health.
Families were assessed during children's kindergarten year (fall semester of 2003, 2004, and 2005) and again during middle childhood (2009-2011) for a follow-up assessment that included anthropometric measures and DNA collection.
How the Study Was Run
The dates of the analysis were January 2015 to June 2016.
What Was Measured
PubMed files the paper under topics including Alleles, Anthropometry, Genetic Predisposition to Disease, Genotype, Pediatric Obesity, Receptors, Oxytocin and Risk Factors.
What This Means in Plain Language
This is an observational study of Oxytocin.
Results are reported in around 8 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2017 (JAMA pediatrics), a journal based in United States.
More context: the Oxytocin compound page, all human trials.
Our Notes on the Compound
Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.